Spesolimab (Anti-IL-1RL2 / IL-36R)

Synonyms: BI 655130

Spesolimab (Anti-IL-1RL2 / IL-36R) is an humanized antagonistic monoclonal antibody targeting IL-36 receptor. It can be used for treatment of palmoplantar pustulosis (PPP) and generalized pustular psoriasis (GPP). MW : 145.5 KD.

Spesolimab (Anti-IL-1RL2 / IL-36R)

Purity & Quality Control

Batch: A244201 Purity: 99% Protein concentration: 4.09mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Spesolimab (Anti-IL-1RL2 / IL-36R) is an humanized antagonistic monoclonal antibody targeting IL-36 receptor. It can be used for treatment of palmoplantar pustulosis (PPP) and generalized pustular psoriasis (GPP). MW : 145.5 KD.

Product Details

CAS No. 2097104-58-8
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Spesolimab (Anti-IL-1RL2 / IL-36R) | Spesolimab (Anti-IL-1RL2 / IL-36R) supplier | purchase Spesolimab (Anti-IL-1RL2 / IL-36R) | Spesolimab (Anti-IL-1RL2 / IL-36R) cost | Spesolimab (Anti-IL-1RL2 / IL-36R) manufacturer | order Spesolimab (Anti-IL-1RL2 / IL-36R) | Spesolimab (Anti-IL-1RL2 / IL-36R) distributor